1. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
2. Department of Hematology and Immunology, Myeloma Center,Vrije Universiteit Brussel, Brussels, Belgium;
3. Advanced Microscopy Program, Center for Systems Biology and Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA;
4. Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;
5. Threshold Pharmaceuticals, Redwood City, CA; and
6. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Children's Hospital Boston and Harvard Medical School, Boston, MA